Related Experiment Video
Updated: Dec 28, 2025

05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
Published on: August 8, 2025
414
The giant aggressive chondroma: A rare entity, a difficult approach.
Carmine Zoccali1, Jacopo Baldi1, Vincenzo Anelli2
1Oncological Orthopaedics Department, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Journal of Orthopaedics
|February 12, 2020
Summary
Large enchondromas of the femur may pose a risk for malignant transformation. This study suggests lesion size is a key factor in the development of secondary chondrosarcoma.
Area of Science:
- Orthopedic Oncology
- Bone Tumors
- Skeletal Radiology
Background:
- Enchondromas are benign bone tumors typically measuring 3-6 cm in long bones.
- The risk of secondary chondrosarcoma in solitary enchondromas is up to 4%.
- The role of enchondroma size as a risk factor for malignant transformation is not well-established.
Purpose of the Study:
- To report three rare cases of enchondromas affecting the entire femur.
- To investigate the potential link between enchondroma size and malignant transformation, specifically dedifferentiation into chondrosarcoma.
Main Methods:
- Case series methodology.
- Clinical and radiological follow-up of patients with large femoral enchondromas.
- Histopathological analysis for cases with suspected malignant change.
Main Results:
- Two patients with large enchondromas demonstrated stable disease over 5 and 6 years.
- One patient, initially presenting with a large enchondroma, developed dedifferentiated chondrosarcoma.
- The patient with dedifferentiated chondrosarcoma experienced disease progression and mortality within 14 months post-surgery.
Conclusions:
- Large enchondromas, particularly those involving the entire femur, may represent a significant risk factor for malignant transformation.
- Lesion size should be considered a critical factor in assessing the risk of enchondroma dedifferentiation into chondrosarcoma.
- Further research is warranted to confirm the association between enchondroma size and malignant potential.

